NFKB1 and breast neoplasm: Hence, we identified 12 out of 18 ER− breast tumours with transcriptionally active NF-κB compared to only 1 out of 19 ER+ breast tumours with transcriptionally active NF-κB (κ=−0.609, P<0.0001).